Mechanism of Action
Sulforaphane belongs to the isothiocyanate family, sulfur-containing compounds that act as molecular alarm signals. Laboratory work describes a brief interaction with sentinel proteins that monitor the cell's internal stress level. This interaction releases transcription factors (proteins that command the reading of specific genes) normally kept in a dormant state.
Once released, these factors migrate to the cell nucleus and trigger, still in the laboratory, the coordinated production of protective enzymes. The process there is transient: the initial signal fades within hours, while the protective response lasts beyond it. This asymmetry between a brief stress and a prolonged defense defines the mechanism as described.
In humans, what trials measure lies downstream of those steps: the body clears more pollutant derivatives in urine, and it does so all the more as sulforaphane exposure rises.
Key Benefits
- Moderate
Measurable support for clearing inhaled pollutants: in 291 adults living in a heavily polluted area, twelve weeks of a broccoli sprout beverage dosed at 600 µmol glucoraphanin and 40 µmol sulforaphane per day raise urinary elimination of benzene derivatives by 61% and of acrolein by 23%. A second trial in 170 adults reproduces the benzene effect, and only at the highest dose.
- Emerging
Lower fasting blood sugar: in adults with obesity whose blood sugar remains poorly regulated, twelve weeks of a concentrated broccoli sprout extract at 150 µmol sulforaphane per day lower fasting blood glucose and glycated haemoglobin.
- Emerging
A preliminary signal on mental speed: in 144 healthy adults aged 60 to 80, twelve weeks of a sulforaphane precursor at 30 mg per day improve processing speed and working memory, in a randomized placebo-controlled trial.
Dosage & Forms
Sulforaphane is available in three main supplementation forms. Free sulforaphane offers immediate bioavailability but degrades at room temperature within weeks, unless a dedicated process stabilizes it. Stabilized glucoraphanin, its biological precursor, remains stable throughout shelf life; it converts to sulforaphane in the intestine through the action of gut bacteria, a conversion whose extent varies widely from person to person. Formulations enriched with exogenous myrosinase speed up that conversion, but their effect depends on gastric conditions that are difficult to control.
Clinical trials in humans administer 25 to 340 µmol of sulforaphane per day, roughly 4 to 60 mg. Singular delivers 20 mg per day, as a broccoli seed extract standardized to 5% free, stabilized sulforaphane, which depends on no enzymatic conversion in the intestine.
In the Singular Formula
Inclusion rationale
Sulphur-containing isothiocyanate from cruciferous vegetables, concentrated in broccoli seeds and young sprouts, where the content of glucoraphanin — its precursor — is ten to one hundred times that of mature broccoli. Sulforaphane is formed by the action of the enzyme myrosinase on glucoraphanin during chewing or processing; the selected extract already supplies it in its free form, without that step. With over three thousand publications, it is one of the most studied plant compounds of the decade. In the laboratory, it triggers a cellular defence programme: a brief molecular stress that sets off the reading of several hundred protective genes, including those of the enzymes that neutralise and clear unwanted compounds. In humans, what is measured lies downstream: in 291 adults exposed to air pollution, twelve weeks of a broccoli sprout beverage raise urinary excretion of benzene derivatives by 61%, and a second trial establishes the dose-response relationship.
Selected form
Sulfodyne® is a broccoli seed extract (Brassica oleracea var. italica) patented by Ingood by Olga, standardized for free, stabilized sulforaphane. Most broccoli extracts supply glucoraphanin, an inactive precursor that gut flora must hydrolyse to release sulforaphane, a conversion that depends on the microbiome and on gastric acidity. A patented stabilization process delivers the isothiocyanate directly in its active form, with no intermediate enzymatic step. European seed origin, manufactured in France.
Formula dosage
0 to 20 mg.
Dose expressed as active substance, excluding excipients and carriers of the raw material.
Synergies in the formula
Linked Biomarkers
Safety & Precautions
Sulforaphane presents a favourable safety profile at the doses used in clinical trials. A phase I study in hospitalized volunteers, over seven days at three doses daily, recorded no abnormal events. Adverse effects reported elsewhere are limited to mild digestive discomfort (bloating, flatulence, loose stools) in a minority of participants.
During pregnancy and breastfeeding, sulforaphane supplementation is not recommended, and the Singular formula leaves it out for these profiles: at a dose equivalent to the one we deliver, a study in eight women found the molecule in umbilical cord blood, in placental tissue and in breast milk, and its effects on the child have not been studied. The product is intended for adults only.
Individuals monitored for thyroid function should inform their physician of sulforaphane intake: at very high doses, isothiocyanates may theoretically interfere with iodine metabolism. A twelve-week randomized trial nevertheless found no effect on thyroid-stimulating hormone, free thyroxine or thyroglobulin.
The track record of use is substantial. Broccoli sprouts have been part of the human diet for decades, and supplementation trials cover durations ranging from a few weeks to twelve months, with one pilot trial extended to forty-two months, and no major safety signal.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Egner PA et al. | 2014 | Randomised Controlled Trial | Cancer Prevention Research | View on PubMed |
Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China Randomized controlled trial in 291 adults from the Qidong region, exposed to high levels of air pollution. Twelve weeks of a broccoli sprout beverage providing 600 µmol glucoraphanin and 40 µmol sulforaphane daily increase urinary excretion of benzene conjugates by 61% and acrolein conjugates by 23%. No effect on crotonaldehyde. | ||||
| Chen JG et al. | 2019 | Randomised Controlled Trial | The American Journal of Clinical Nutrition | View on PubMed |
Dose-dependent detoxication of the airborne pollutant benzene in a randomized trial of broccoli sprout beverage in Qidong, China Randomized placebo-controlled trial in 170 adults, with three concentrations of the same beverage over ten days. Only the highest dose, the one leading to a median urinary output of 24.6 µmol of sulforaphane metabolites per day, significantly increases benzene elimination (+63.2%). The half dose (10.3 µmol) and one-fifth dose (4.3 µmol) do not differ from placebo. This trial sets the exposure to reach. | ||||
| Axelsson AS et al. | 2017 | Randomised Controlled Trial | Science Translational Medicine | View on PubMed |
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes Twelve-week randomized trial. A concentrated broccoli sprout extract providing 150 µmol sulforaphane per day lowers fasting blood glucose and glycated haemoglobin in participants with obesity whose blood sugar was the least well regulated. The full text is not open access: the elements reported here are those the authors state in their abstract. | ||||
| Dwibedi C et al. | 2025 | Randomised Controlled Trial | Nature Microbiology | View on PubMed |
Effect of broccoli sprout extract and baseline gut microbiota on fasting blood glucose in prediabetes: a randomized, placebo-controlled trial The replication, and it is partial. In 74 adults with disturbed fasting blood glucose, twelve weeks of the same extract at 150 µmol per day do not meet the primary endpoint set at 0.3 mmol/L: the observed drop is 0.2 mmol/L. It concentrates on participants whose gut flora carries the gene required to convert the precursor. Gastrointestinal side effects, no serious events. | ||||
| Nouchi R et al. | 2021 | Randomised Controlled Trial | Nutrients | View on PubMed |
Brain Training and Sulforaphane Intake Interventions Separately Improve Cognitive Performance in Healthy Older Adults Four-arm double-blind randomized trial in 144 healthy adults aged 60 to 80. Twelve weeks of a supplement providing 30 mg glucoraphanin per day improve processing speed and working memory versus placebo, independently of the associated cognitive training. The authors find no correlation between the size of the gain and the amount of sulforaphane recovered in urine. | ||||
| Egner PA et al. | 2011 | Randomised Controlled Trial | Cancer Prevention Research | View on PubMed |
Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China Crossover trial in 50 adults, who receive both forms in turn. Measured by urinary excretion of sulforaphane and its metabolites, bioavailability averages 70% with the sulforaphane-rich beverage versus 5% with the glucoraphanin-rich one; person-to-person variability is markedly lower with the former. This is the comparison that justifies choosing a free form. | ||||
| Shapiro TA et al. | 2006 | Randomised Controlled Trial | Nutrition and Cancer | View on PubMed |
Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study Double-blind, placebo-controlled phase I study in healthy hospitalized volunteers receiving the extract every eight hours for seven days. Thirty-two laboratory parameters were monitored, including transaminases and thyroid function: no abnormal event, subjective or objective, was observed. The study also establishes that the isothiocyanate form is excreted at 70.6% of dose, versus 17.8 to 19.6% for the glucosinolate form. | ||||